Physician profile
Thomas Matthew
NPI 1750372231
$4,613.40
in general payments reported to CMS, 2019-2025
13 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $1,444 · 2021: $62.86 · 2022: $577 · 2023: $370 · 2024: $345 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,427.86 | 2020 | |
| Medtronic, INC. | $1,244.77 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $568.13 | 2019-2025 | Impella |
| Atricure, INC. | $486.77 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Edwards Lifesciences Corporation | $230.84 | 2019-2025 | Konect Resilia |
| Getinge USA Sales, LLC | $177.34 | 2019-2024 | Vasoview Hemopro 2 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.61 | 2019-2025 | Lifevest |
| Zimmer Biomet Holdings, INC. | $129.17 | 2025 | Sternalock |
| Biom'Up Sa | $81.31 | 2019 | |
| Cook Medical LLC | $44.75 | 2019-2024 | Cook |
| Organogenesis INC. | $34.30 | 2024 | |
| Scpharmaceuticals INC. | $26.55 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Matthew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.